Shopping Cart 0
Cart Subtotal
USD 0

Alopecia Treatment Market by Drug Type (Minoxidil, Finasteride, and Other Drug Types), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, and Others), and Distribution Channel (Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2019-2026

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 5370

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8995

Details

The global alopecia treatment market was valued at USD 2,736 million in 2018, and is projected to reach USD 3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
 
Alopecia is a term used to describe extreme hair loss or hair damage under certain dietary issues and medical conditions. It is a common autoimmune disease, which causes bald spots resulting in partial or complete hair loss. It can affect persons of all gender and at any stage of life, it commonly affects mid-aged generation. Various hair transplant therapies and drugs can be used for the treatment of alopecia condition. Treatment of alopecia condition can be carried out using drugs such as minoxidil, finasteride, and other drugs.
 
Significant increase in prevalence of chronic diseases such as hypertension, arthritis, Polycystic Ovary Syndrome (PCOS), and depression; rise in geriatric population; hormonal imbalance; high level of stress; increase in consumption of alcohol & tobacco, change in food habits, and increase in prevalence of chemotherapy induced alopecia fuel the growth of the alopecia treatment market. Moreover, rise in awareness programs for alopecia treatment & management; increase in prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others; and genetic factors might contribute toward rise in incidences of alopecia among both men & women are other factors that contribute toward the growth of the market. However, poor demand for alopecia treatment drugs in underdeveloped countries are expected to hinder the growth of the market.
 
The alopecia treatment market is segmented into drug type, indication, distribution channel, and region. By drug type, the market is categorized into minoxidil, finasteride, and other drug types. The indication covered in the study include androgenic alopecia, alopecia areata, alopecia totalis, and others. Depending on distribution channel, the market is classified into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
 
 
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
 
KEY MARKET SEGMENTS
By Drug Type
Minoxidil
Finasteride
Other Drug Types
By Indication
Androgenic Alopecia
Alopecia Areata
Alopecia Totalis
Others
By End User
Hospitals Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Region
 
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Capillus, LLC
Cipla Inc.
Daiichi Sankyo Company, Limited
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd.
Transitions Hair
Vitabiotics Ltd.
Vita-Cos-Med Klett-Loch GmbH
 
 
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Dr. Reddy's Laboratories
Concert Pharmaceuticals Inc.
Aclaris Therapeutics, Inc.
 
 
READ MORE

Table Of Content

Scope

Chapter 1: Introduction

 

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

 

1.3.1. List of Key Players Profiled In The Report

 

1.4. Research Methodology

 

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools And Models

 

Chapter 2: Executive Summary

 

2.1. Key Findings of The Study

2.2. Cxo Perspective

 

Chapter 3: Market Overview

 

3.1. Market Definition And Scope

3.2. Key Findings

 

3.2.1. Top Investment Pockets

 

3.3. Porter'S Five Force Analysis

3.4. Market Dynamics

 

3.4.1. Drivers

 

3.4.1.1. Increase In Chronic Diseases To Lead To Hair Loss

3.4.1.2. Surge In Global Geriatric Population

3.4.1.3. Increase In Government Expenditure On Healthcare

 

3.4.2. Restraint

 

3.4.2.1. Poor Demand In Under Developed Countries

 

3.4.3. Opportunities

 

3.4.3.1. Growth Opportunities In Emerging Markets

 

3.4.4. Impact Analysis

 

Chapter 4: Alopecia Treatment Market, By Drug Type

 

4.1. Overview

 

4.1.1. Market Size And Forecast

 

4.2. Minoxidil

 

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast, By Region

4.2.3. Market Analysis, By Country

 

4.3. Finasteride

 

4.3.1. Key Market Trends And Opportunities

4.3.2. Market Size And Forecast, By Region

4.3.3. Market Analysis, By Country

 

4.4. Other Drug Types

 

4.4.1. Key Market Trends And Opportunities

4.4.2. Market Size And Forecast, By Region

4.4.3. Market Analysis, By Country

 

Chapter 5: Alopecia Treatment Market, By Indication

 

5.1. Overview

 

5.1.1. Market Size And Forecast

 

5.2. Androgenic Alopecia

 

5.2.1. Market Size And Forecast

5.2.2. Market Analysis, By Country

 

5.3. Alopecia Areata

 

5.3.1. Market Size And Forecast

5.3.2. Market Analysis, By Country

 

5.4. Alopecia Totalis

 

5.4.1. Market Size And Forecast

5.4.2. Market Analysis, By Country

 

5.5. Others

 

5.5.1. Market Size And Forecast

5.5.2. Market Analysis, By Country

 

Chapter 6: Alopecia Treatment Market, By Distribution Channel

 

6.1. Overview

 

6.1.1. Market Size And Forecast

 

6.2. Hospitals Pharmacies

 

6.2.1. Market Size And Forecast

6.2.2. Market Analysis, By Country

 

6.3. Drug Stores & Retail Pharmacies

 

6.3.1. Market Size And Forecast

6.3.2. Market Analysis, By Country

 

6.4. Online Pharmacies

 

6.4.1. Market Size And Forecast

6.4.2. Market Analysis, By Country

 

Chapter 7: Alopecia Treatment Market, By Region

 

7.1. Overview

 

7.1.1. Market Size And Forecast

 

7.2. North America

 

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. Market Size And Forecast, By Country

 

7.2.2.1. U.S.

 

7.2.2.1.1. U.S. Alopecia Treatment Market, By Drug Type

7.2.2.1.2. U.S. Alopecia Treatment Market, By Indication

7.2.2.1.3. U.S. Alopecia Treatment Market, By Distribution Channel

 

7.3. North America

 

7.3.1. Key Market Trends, Growth Factors, And Opportunities

7.3.2. Market Size And Forecast, By Country

 

7.3.2.1. U.S.

 

7.3.2.1.1. U.S. Alopecia Treatment Market, By Drug Type

7.3.2.1.2. U.S. Alopecia Treatment Market, By Indication

7.3.2.1.3. U.S. Alopecia Treatment Market, By Distribution Channel

 

7.3.2.2. Canada

 

7.3.2.2.1. Canada Alopecia Treatment Market, By Drug Type

7.3.2.2.2. Canada Alopecia Treatment Market, By Indication

7.3.2.2.3. Canada Alopecia Treatment Market, By Distribution Channel

 

7.3.2.3. Mexico

 

7.3.2.3.1. Mexico Alopecia Treatment Market, By Drug Type

7.3.2.3.2. Mexico Alopecia Treatment Market, By Indication

7.3.2.3.3. Mexico Alopecia Treatment Market, By Distribution Channel

 

7.3.3. North America Market Size And Forecast, By Drug Type

7.3.4. North America Market Size And Forecast, By Indication

7.3.5. North America Market Size And Forecast, By Distribution Channel

 

7.4. Europe

 

7.4.1. Key Market Trends, Growth Factors, And Opportunities

7.4.2. Market Size And Forecast, By Country

 

7.4.2.1. Germany

 

7.4.2.1.1. Germany Alopecia Treatment Market, By Drug Type

7.4.2.1.2. Germany Alopecia Treatment Market, By Indication

7.4.2.1.3. Germany Alopecia Treatment Market, By Distribution Channel

 

7.4.2.2. France

 

7.4.2.2.1. France Alopecia Treatment Market, By Drug Type

7.4.2.2.2. France Alopecia Treatment Market, By Indication

7.4.2.2.3. France Alopecia Treatment Market, By Distribution Channel

 

7.4.2.3. Uk

 

7.4.2.3.1. Uk Alopecia Treatment Market, By Drug Type

7.4.2.3.2. Uk Alopecia Treatment Market, By Indication

7.4.2.3.3. Uk Alopecia Treatment Market, By Distribution Channel

 

7.4.2.4. Italy

 

7.4.2.4.1. Italy Alopecia Treatment Market, By Drug Type

7.4.2.4.2. Italy Alopecia Treatment Market, By Indication

7.4.2.4.3. Italy Alopecia Treatment Market, By Distribution Channel

 

7.4.2.5. Spain

 

7.4.2.5.1. Spain Alopecia Treatment Market, By Drug Type

7.4.2.5.2. Spain Alopecia Treatment Market, By Indication

7.4.2.5.3. Spain Alopecia Treatment Market, By Distribution Channel

 

7.4.2.6. Rest of Europe

 

7.4.2.6.1. Rest of Europe Alopecia Treatment Market, By Drug Type

7.4.2.6.2. Rest of Europe Alopecia Treatment Market, By Indication

7.4.2.6.3. Rest of Europe Alopecia Treatment Market, By Distribution Channel

 

7.4.3. Europe Market Size And Forecast, By Drug Type

7.4.4. Europe Market Size And Forecast, By Indication

7.4.5. Europe Market Size And Forecast, By Distribution Channel

 

7.5. Asia-Pacific

 

7.5.1. Key Market Trends, Growth Factors, And Opportunities

7.5.2. Market Size And Forecast, By Country

 

7.5.2.1. Japan

 

7.5.2.1.1. Japan Alopecia Treatment Market, By Drug Type

7.5.2.1.2. Japan Alopecia Treatment Market, By Indication

7.5.2.1.3. Japan Alopecia Treatment Market, By Distribution Channel

 

7.5.2.2. China

 

7.5.2.2.1. China Alopecia Treatment Market, By Drug Type

7.5.2.2.2. China Alopecia Treatment Market, By Indication

7.5.2.2.3. China Alopecia Treatment Market, By Distribution Channel

 

7.5.2.3. Australia

 

7.5.2.3.1. Australia Alopecia Treatment Market, By Drug Type

7.5.2.3.2. Australia Alopecia Treatment Market, By Indication

7.5.2.3.3. Australia Alopecia Treatment Market, By Distribution Channel

 

7.5.2.4. India

 

7.5.2.4.1. India Alopecia Treatment Market, By Drug Type

7.5.2.4.2. India Alopecia Treatment Market, By Indication

7.5.2.4.3. India Alopecia Treatment Market, By Distribution Channel

 

7.5.2.5. South Korea

 

7.5.2.5.1. South Korea Alopecia Treatment Market, By Drug Type

7.5.2.5.2. South Korea Alopecia Treatment Market, By Indication

7.5.2.5.3. South Korea Alopecia Treatment Market, By Distribution Channel

 

7.5.2.6. Rest of Asia-Pacific

 

7.5.2.6.1. Rest of Asia-Pacific Alopecia Treatment Market, By Drug Type

7.5.2.6.2. Rest of Asia-Pacific Alopecia Treatment Market, By Indication

7.5.2.6.3. Rest of Asia-Pacific Alopecia Treatment Market, By Distribution Channel

 

7.5.3. Asia-Pacific Market Size And Forecast, By Drug Type

7.5.4. Asia-Pacific Market Size And Forecast, By Indication

7.5.5. Asia-Pacific Market Size And Forecast, By Distribution Channel

 

7.6. Lamea

 

7.6.1. Key Market Trends, Growth Factors, And Opportunities

7.6.2. Market Size And Forecast, By Country

 

7.6.2.1. Brazil

 

7.6.2.1.1. Brazil Alopecia Treatment Market, By Drug Type

7.6.2.1.2. Brazil Alopecia Treatment Market, By Indication

7.6.2.1.3. Brazil Alopecia Treatment Market, By Distribution Channel

 

7.6.2.2. Saudi Arabia

 

7.6.2.2.1. Saudi Arabia Alopecia Treatment Market, By Drug Type

7.6.2.2.2. Saudi Arabia Alopecia Treatment Market, By Indication

7.6.2.2.3. Saudi Arabia Alopecia Treatment Market, By Distribution Channel

 

7.6.2.3. South Africa

 

7.6.2.3.1. South Africa Alopecia Treatment Market, By Drug Type

7.6.2.3.2. South Africa Alopecia Treatment Market, By Indication

7.6.2.3.3. South Africa Alopecia Treatment Market, By Distribution Channel

 

7.6.2.4. Rest of Lamea

 

7.6.2.4.1. Rest of Lamea Alopecia Treatment Market, By Drug Type

7.6.2.4.2. Rest of Lamea Alopecia Treatment Market, By Indication

7.6.2.4.3. Rest of Lamea Alopecia Treatment Market, By Distribution Channel

 

7.6.3. Lamea Market Size And Forecast, By Drug Type

7.6.4. Lamea Market Size And Forecast, By Indication

7.6.5. Lamea Market Size And Forecast, By Distribution Channel


List Of Figure

List of Figures

 

Figure 01. Global Alopecia Treatment Market Segmentation

Figure 02. Top Investment Pockets, 2018

Figure 03. Moderate Bargaining Power of Suppliers

Figure 04. Moderate Bargaining Power of Buyers

Figure 05. Moderate Threat of Substitutes

Figure 06. Low Threat of New Entrants

Figure 07. Moderate Intensity of Rivalry

Figure 08. Impact Analysis

Figure 09. Comparative Analysis of Minoxidil Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 10. Comparative Analysis of Finasteride Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 11. Comparative Analysis of Other Drug Types Market, By Country, 2018 & 2026 (USD Million)

Figure 12. Comparative Analysis of Androgenic Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 13. Comparative Analysis of Alopecia Areata Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 14. Comparative Analysis of Alopecia Totalis Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 15. Comparative Analysis of Others Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 16. Comparative Analysis of Hospitals Pharmacies Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 17. Comparative Analysis Drug Stores & Retail Pharmacies Alopecia Treatment Market, By Country, 2018 & 2026 (%)

Figure 18. Comparative Analysis of Online Pharmacies Alopecia Treatment Market, By Country, 2018 & 2026 (%)

 


List Of Table

List of Tables

 

Table 01. Global Alopecia Treatment Market, By Drug Type, 2018-2026 (USD Million)

Table 02. Minoxidil Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 03. Finasteride Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 04. Other Drug Types Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 05. Global Alopecia Treatment Market, By Indication, 2018-2026 (USD Million)

Table 06. Androgenic Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 07. Alopecia Areata Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 08. Alopecia Totalis Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 09. Others Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 10. Global Alopecia Treatment Market, By Distribution Channel, 2018-2026 (USD Million)

Table 11. Hospitals Pharmacies Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 12. Drug Stores & Retail Pharmacies Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 13. Online Pharmacies Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 14. Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 15. North America Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 16. U.S. Alopecia Treatment Market, By Drug Type, 2018-2026

Table 17. U.S. Alopecia Treatment Market, By Indication, 2018-2026

Table 18. U.S. Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 19. North America Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 20. U.S. Alopecia Treatment Market, By Drug Type, 2018-2026

Table 21. U.S. Alopecia Treatment Market, By Indication, 2018-2026

Table 22. U.S. Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 23. Canada Alopecia Treatment Market, By Drug Type, 2018-2026

Table 24. Canada Alopecia Treatment Market, By Indication, 2018-2026

Table 25. Canada Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 26. Mexico Alopecia Treatment Market, By Drug Type, 2018-2026

Table 27. Mexico Alopecia Treatment Market, By Indication, 2018-2026

Table 28. Mexico Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 29. North America Alopecia Treatment Market, By Drug Type, 2018-2026

Table 30. North America Alopecia Treatment Market, By Indication, 2018-2026

Table 31. North America Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 32. Europe Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 33. Germany Alopecia Treatment Market, By Drug Type, 2018-2026

Table 34. Germany Alopecia Treatment Market, By Indication, 2018-2026

Table 35. Germany Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 36. France Alopecia Treatment Market, By Drug Type, 2018-2026

Table 37. France Alopecia Treatment Market, By Indication, 2018-2026

Table 38. France Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 39. Uk Alopecia Treatment Market, By Drug Type, 2018-2026

Table 40. Uk Alopecia Treatment Market, By Indication, 2018-2026

Table 41. Uk Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 42. Italy Alopecia Treatment Market, By Drug Type, 2018-2026

Table 43. Italy Alopecia Treatment Market, By Indication, 2018-2026

Table 44. Italy Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 45. Spain Alopecia Treatment Market, By Drug Type, 2018-2026

Table 46. Spain Alopecia Treatment Market, By Indication, 2018-2026

Table 47. Spain Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 48. Rest of Europe Alopecia Treatment Market, By Drug Type, 2018-2026

Table 49. Rest of Europe Alopecia Treatment Market, By Indication, 2018-2026

Table 50. Rest of Europe Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 51. Europe Alopecia Treatment Market, By Drug Type, 2018-2026

Table 52. Europe Alopecia Treatment Market, By Indication, 2018-2026

Table 53. Europe Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 54. Asia-Pacific Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 55. Japan Alopecia Treatment Market, By Drug Type, 2018-2026

Table 56. Japan Alopecia Treatment Market, By Indication, 2018-2026

Table 57. Japan Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 58. China Alopecia Treatment Market, By Drug Type, 2018-2026

Table 59. China Alopecia Treatment Market, By Indication, 2018-2026

Table 60. China Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 61. Australia Alopecia Treatment Market, By Drug Type, 2018-2026

Table 62. Australia Alopecia Treatment Market, By Indication, 2018-2026

Table 63. Australia Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 64. India Alopecia Treatment Market, By Drug Type, 2018-2026

Table 65. India Alopecia Treatment Market, By Indication, 2018-2026

Table 66. India Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 67. South Korea Alopecia Treatment Market, By Drug Type, 2018-2026

Table 68. South Korea Alopecia Treatment Market, By Indication, 2018-2026

Table 69. South Korea Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 70. Rest of Asia-Pacific Alopecia Treatment Market, By Drug Type, 2018-2026

Table 71. Rest of Asia-Pacific Alopecia Treatment Market, By Indication, 2018-2026

Table 72. Rest of Asia-Pacific Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 73. Asia-Pacific Alopecia Treatment Market, By Drug Type, 2018-2026

Table 74. Asia-Pacific Alopecia Treatment Market, By Indication, 2018-2026

Table 75. Asia-Pacific Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 76. Lamea Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 77. Brazil Alopecia Treatment Market, By Drug Type, 2018-2026

Table 78. Brazil Alopecia Treatment Market, By Indication, 2018-2026

Table 79. Brazil Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 80. Saudi Arabia Alopecia Treatment Market, By Drug Type, 2018-2026

Table 81. Saudi Arabia Alopecia Treatment Market, By Indication, 2018-2026

Table 82. Saudi Arabia Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 83. South Africa Alopecia Treatment Market, By Drug Type, 2018-2026

Table 84. South Africa Alopecia Treatment Market, By Indication, 2018-2026

Table 85. South Africa Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 86. Rest of Lamea Alopecia Treatment Market, By Drug Type, 2018-2026

Table 87. Rest of Lamea Alopecia Treatment Market, By Indication, 2018-2026

Table 88. Rest of Lamea Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 89. Lamea Alopecia Treatment Market, By Drug Type, 2018-2026

Table 90. Lamea Alopecia Treatment Market, By Indication, 2018-2026

Table 91. Lamea Alopecia Treatment Market, By Distribution Channel, 2018-2026

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Capillus, LLC, Cipla Inc., Daiichi Sankyo Company, Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Transitions Hair, Vitabiotics Ltd., and Vita-Cos-Med Klett-Loch GmbH.

Company Profile

Company Profile Title

The global alopecia treatment market was valued at USD 2,736 million in 2018, and is projected to reach USD 3,935 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
 
Alopecia is a term used to describe extreme hair loss or hair damage under certain dietary issues and medical conditions. It is a common autoimmune disease, which causes bald spots resulting in partial or complete hair loss. It can affect persons of all gender and at any stage of life, it commonly affects mid-aged generation. Various hair transplant therapies and drugs can be used for the treatment of alopecia condition. Treatment of alopecia condition can be carried out using drugs such as minoxidil, finasteride, and other drugs.
 
Significant increase in prevalence of chronic diseases such as hypertension, arthritis, Polycystic Ovary Syndrome (PCOS), and depression; rise in geriatric population; hormonal imbalance; high level of stress; increase in consumption of alcohol & tobacco, change in food habits, and increase in prevalence of chemotherapy induced alopecia fuel the growth of the alopecia treatment market. Moreover, rise in awareness programs for alopecia treatment & management; increase in prevalence of alopecia conditions such as androgenic alopecia, alopecia areata, alopecia totalis, and others; and genetic factors might contribute toward rise in incidences of alopecia among both men & women are other factors that contribute toward the growth of the market. However, poor demand for alopecia treatment drugs in underdeveloped countries are expected to hinder the growth of the market.
 
The alopecia treatment market is segmented into drug type, indication, distribution channel, and region. By drug type, the market is categorized into minoxidil, finasteride, and other drug types. The indication covered in the study include androgenic alopecia, alopecia areata, alopecia totalis, and others. Depending on distribution channel, the market is classified into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
 
 
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
 
KEY MARKET SEGMENTS
By Drug Type
Minoxidil
Finasteride
Other Drug Types
By Indication
Androgenic Alopecia
Alopecia Areata
Alopecia Totalis
Others
By End User
Hospitals Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
By Region
 
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Capillus, LLC
Cipla Inc.
Daiichi Sankyo Company, Limited
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co., Inc.
Sun Pharmaceutical Industries Ltd.
Transitions Hair
Vitabiotics Ltd.
Vita-Cos-Med Klett-Loch GmbH
 
 
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Dr. Reddy's Laboratories
Concert Pharmaceuticals Inc.
Aclaris Therapeutics, Inc.
 
 
READ MORE

Scope

Chapter 1: Introduction

 

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

 

1.3.1. List of Key Players Profiled In The Report

 

1.4. Research Methodology

 

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools And Models

 

Chapter 2: Executive Summary

 

2.1. Key Findings of The Study

2.2. Cxo Perspective

 

Chapter 3: Market Overview

 

3.1. Market Definition And Scope

3.2. Key Findings

 

3.2.1. Top Investment Pockets

 

3.3. Porter'S Five Force Analysis

3.4. Market Dynamics

 

3.4.1. Drivers

 

3.4.1.1. Increase In Chronic Diseases To Lead To Hair Loss

3.4.1.2. Surge In Global Geriatric Population

3.4.1.3. Increase In Government Expenditure On Healthcare

 

3.4.2. Restraint

 

3.4.2.1. Poor Demand In Under Developed Countries

 

3.4.3. Opportunities

 

3.4.3.1. Growth Opportunities In Emerging Markets

 

3.4.4. Impact Analysis

 

Chapter 4: Alopecia Treatment Market, By Drug Type

 

4.1. Overview

 

4.1.1. Market Size And Forecast

 

4.2. Minoxidil

 

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast, By Region

4.2.3. Market Analysis, By Country

 

4.3. Finasteride

 

4.3.1. Key Market Trends And Opportunities

4.3.2. Market Size And Forecast, By Region

4.3.3. Market Analysis, By Country

 

4.4. Other Drug Types

 

4.4.1. Key Market Trends And Opportunities

4.4.2. Market Size And Forecast, By Region

4.4.3. Market Analysis, By Country

 

Chapter 5: Alopecia Treatment Market, By Indication

 

5.1. Overview

 

5.1.1. Market Size And Forecast

 

5.2. Androgenic Alopecia

 

5.2.1. Market Size And Forecast

5.2.2. Market Analysis, By Country

 

5.3. Alopecia Areata

 

5.3.1. Market Size And Forecast

5.3.2. Market Analysis, By Country

 

5.4. Alopecia Totalis

 

5.4.1. Market Size And Forecast

5.4.2. Market Analysis, By Country

 

5.5. Others

 

5.5.1. Market Size And Forecast

5.5.2. Market Analysis, By Country

 

Chapter 6: Alopecia Treatment Market, By Distribution Channel

 

6.1. Overview

 

6.1.1. Market Size And Forecast

 

6.2. Hospitals Pharmacies

 

6.2.1. Market Size And Forecast

6.2.2. Market Analysis, By Country

 

6.3. Drug Stores & Retail Pharmacies

 

6.3.1. Market Size And Forecast

6.3.2. Market Analysis, By Country

 

6.4. Online Pharmacies

 

6.4.1. Market Size And Forecast

6.4.2. Market Analysis, By Country

 

Chapter 7: Alopecia Treatment Market, By Region

 

7.1. Overview

 

7.1.1. Market Size And Forecast

 

7.2. North America

 

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. Market Size And Forecast, By Country

 

7.2.2.1. U.S.

 

7.2.2.1.1. U.S. Alopecia Treatment Market, By Drug Type

7.2.2.1.2. U.S. Alopecia Treatment Market, By Indication

7.2.2.1.3. U.S. Alopecia Treatment Market, By Distribution Channel

 

7.3. North America

 

7.3.1. Key Market Trends, Growth Factors, And Opportunities

7.3.2. Market Size And Forecast, By Country

 

7.3.2.1. U.S.

 

7.3.2.1.1. U.S. Alopecia Treatment Market, By Drug Type

7.3.2.1.2. U.S. Alopecia Treatment Market, By Indication

7.3.2.1.3. U.S. Alopecia Treatment Market, By Distribution Channel

 

7.3.2.2. Canada

 

7.3.2.2.1. Canada Alopecia Treatment Market, By Drug Type

7.3.2.2.2. Canada Alopecia Treatment Market, By Indication

7.3.2.2.3. Canada Alopecia Treatment Market, By Distribution Channel

 

7.3.2.3. Mexico

 

7.3.2.3.1. Mexico Alopecia Treatment Market, By Drug Type

7.3.2.3.2. Mexico Alopecia Treatment Market, By Indication

7.3.2.3.3. Mexico Alopecia Treatment Market, By Distribution Channel

 

7.3.3. North America Market Size And Forecast, By Drug Type

7.3.4. North America Market Size And Forecast, By Indication

7.3.5. North America Market Size And Forecast, By Distribution Channel

 

7.4. Europe

 

7.4.1. Key Market Trends, Growth Factors, And Opportunities

7.4.2. Market Size And Forecast, By Country

 

7.4.2.1. Germany

 

7.4.2.1.1. Germany Alopecia Treatment Market, By Drug Type

7.4.2.1.2. Germany Alopecia Treatment Market, By Indication

7.4.2.1.3. Germany Alopecia Treatment Market, By Distribution Channel

 

7.4.2.2. France

 

7.4.2.2.1. France Alopecia Treatment Market, By Drug Type

7.4.2.2.2. France Alopecia Treatment Market, By Indication

7.4.2.2.3. France Alopecia Treatment Market, By Distribution Channel

 

7.4.2.3. Uk

 

7.4.2.3.1. Uk Alopecia Treatment Market, By Drug Type

7.4.2.3.2. Uk Alopecia Treatment Market, By Indication

7.4.2.3.3. Uk Alopecia Treatment Market, By Distribution Channel

 

7.4.2.4. Italy

 

7.4.2.4.1. Italy Alopecia Treatment Market, By Drug Type

7.4.2.4.2. Italy Alopecia Treatment Market, By Indication

7.4.2.4.3. Italy Alopecia Treatment Market, By Distribution Channel

 

7.4.2.5. Spain

 

7.4.2.5.1. Spain Alopecia Treatment Market, By Drug Type

7.4.2.5.2. Spain Alopecia Treatment Market, By Indication

7.4.2.5.3. Spain Alopecia Treatment Market, By Distribution Channel

 

7.4.2.6. Rest of Europe

 

7.4.2.6.1. Rest of Europe Alopecia Treatment Market, By Drug Type

7.4.2.6.2. Rest of Europe Alopecia Treatment Market, By Indication

7.4.2.6.3. Rest of Europe Alopecia Treatment Market, By Distribution Channel

 

7.4.3. Europe Market Size And Forecast, By Drug Type

7.4.4. Europe Market Size And Forecast, By Indication

7.4.5. Europe Market Size And Forecast, By Distribution Channel

 

7.5. Asia-Pacific

 

7.5.1. Key Market Trends, Growth Factors, And Opportunities

7.5.2. Market Size And Forecast, By Country

 

7.5.2.1. Japan

 

7.5.2.1.1. Japan Alopecia Treatment Market, By Drug Type

7.5.2.1.2. Japan Alopecia Treatment Market, By Indication

7.5.2.1.3. Japan Alopecia Treatment Market, By Distribution Channel

 

7.5.2.2. China

 

7.5.2.2.1. China Alopecia Treatment Market, By Drug Type

7.5.2.2.2. China Alopecia Treatment Market, By Indication

7.5.2.2.3. China Alopecia Treatment Market, By Distribution Channel

 

7.5.2.3. Australia

 

7.5.2.3.1. Australia Alopecia Treatment Market, By Drug Type

7.5.2.3.2. Australia Alopecia Treatment Market, By Indication

7.5.2.3.3. Australia Alopecia Treatment Market, By Distribution Channel

 

7.5.2.4. India

 

7.5.2.4.1. India Alopecia Treatment Market, By Drug Type

7.5.2.4.2. India Alopecia Treatment Market, By Indication

7.5.2.4.3. India Alopecia Treatment Market, By Distribution Channel

 

7.5.2.5. South Korea

 

7.5.2.5.1. South Korea Alopecia Treatment Market, By Drug Type

7.5.2.5.2. South Korea Alopecia Treatment Market, By Indication

7.5.2.5.3. South Korea Alopecia Treatment Market, By Distribution Channel

 

7.5.2.6. Rest of Asia-Pacific

 

7.5.2.6.1. Rest of Asia-Pacific Alopecia Treatment Market, By Drug Type

7.5.2.6.2. Rest of Asia-Pacific Alopecia Treatment Market, By Indication

7.5.2.6.3. Rest of Asia-Pacific Alopecia Treatment Market, By Distribution Channel

 

7.5.3. Asia-Pacific Market Size And Forecast, By Drug Type

7.5.4. Asia-Pacific Market Size And Forecast, By Indication

7.5.5. Asia-Pacific Market Size And Forecast, By Distribution Channel

 

7.6. Lamea

 

7.6.1. Key Market Trends, Growth Factors, And Opportunities

7.6.2. Market Size And Forecast, By Country

 

7.6.2.1. Brazil

 

7.6.2.1.1. Brazil Alopecia Treatment Market, By Drug Type

7.6.2.1.2. Brazil Alopecia Treatment Market, By Indication

7.6.2.1.3. Brazil Alopecia Treatment Market, By Distribution Channel

 

7.6.2.2. Saudi Arabia

 

7.6.2.2.1. Saudi Arabia Alopecia Treatment Market, By Drug Type

7.6.2.2.2. Saudi Arabia Alopecia Treatment Market, By Indication

7.6.2.2.3. Saudi Arabia Alopecia Treatment Market, By Distribution Channel

 

7.6.2.3. South Africa

 

7.6.2.3.1. South Africa Alopecia Treatment Market, By Drug Type

7.6.2.3.2. South Africa Alopecia Treatment Market, By Indication

7.6.2.3.3. South Africa Alopecia Treatment Market, By Distribution Channel

 

7.6.2.4. Rest of Lamea

 

7.6.2.4.1. Rest of Lamea Alopecia Treatment Market, By Drug Type

7.6.2.4.2. Rest of Lamea Alopecia Treatment Market, By Indication

7.6.2.4.3. Rest of Lamea Alopecia Treatment Market, By Distribution Channel

 

7.6.3. Lamea Market Size And Forecast, By Drug Type

7.6.4. Lamea Market Size And Forecast, By Indication

7.6.5. Lamea Market Size And Forecast, By Distribution Channel


List Of Figure

List of Figures

 

Figure 01. Global Alopecia Treatment Market Segmentation

Figure 02. Top Investment Pockets, 2018

Figure 03. Moderate Bargaining Power of Suppliers

Figure 04. Moderate Bargaining Power of Buyers

Figure 05. Moderate Threat of Substitutes

Figure 06. Low Threat of New Entrants

Figure 07. Moderate Intensity of Rivalry

Figure 08. Impact Analysis

Figure 09. Comparative Analysis of Minoxidil Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 10. Comparative Analysis of Finasteride Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 11. Comparative Analysis of Other Drug Types Market, By Country, 2018 & 2026 (USD Million)

Figure 12. Comparative Analysis of Androgenic Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 13. Comparative Analysis of Alopecia Areata Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 14. Comparative Analysis of Alopecia Totalis Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 15. Comparative Analysis of Others Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 16. Comparative Analysis of Hospitals Pharmacies Alopecia Treatment Market, By Country, 2018 & 2026 (USD Million)

Figure 17. Comparative Analysis Drug Stores & Retail Pharmacies Alopecia Treatment Market, By Country, 2018 & 2026 (%)

Figure 18. Comparative Analysis of Online Pharmacies Alopecia Treatment Market, By Country, 2018 & 2026 (%)

 


List Of Table

List of Tables

 

Table 01. Global Alopecia Treatment Market, By Drug Type, 2018-2026 (USD Million)

Table 02. Minoxidil Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 03. Finasteride Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 04. Other Drug Types Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 05. Global Alopecia Treatment Market, By Indication, 2018-2026 (USD Million)

Table 06. Androgenic Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 07. Alopecia Areata Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 08. Alopecia Totalis Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 09. Others Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 10. Global Alopecia Treatment Market, By Distribution Channel, 2018-2026 (USD Million)

Table 11. Hospitals Pharmacies Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 12. Drug Stores & Retail Pharmacies Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 13. Online Pharmacies Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 14. Alopecia Treatment Market, By Region, 2018-2026 (USD Million)

Table 15. North America Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 16. U.S. Alopecia Treatment Market, By Drug Type, 2018-2026

Table 17. U.S. Alopecia Treatment Market, By Indication, 2018-2026

Table 18. U.S. Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 19. North America Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 20. U.S. Alopecia Treatment Market, By Drug Type, 2018-2026

Table 21. U.S. Alopecia Treatment Market, By Indication, 2018-2026

Table 22. U.S. Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 23. Canada Alopecia Treatment Market, By Drug Type, 2018-2026

Table 24. Canada Alopecia Treatment Market, By Indication, 2018-2026

Table 25. Canada Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 26. Mexico Alopecia Treatment Market, By Drug Type, 2018-2026

Table 27. Mexico Alopecia Treatment Market, By Indication, 2018-2026

Table 28. Mexico Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 29. North America Alopecia Treatment Market, By Drug Type, 2018-2026

Table 30. North America Alopecia Treatment Market, By Indication, 2018-2026

Table 31. North America Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 32. Europe Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 33. Germany Alopecia Treatment Market, By Drug Type, 2018-2026

Table 34. Germany Alopecia Treatment Market, By Indication, 2018-2026

Table 35. Germany Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 36. France Alopecia Treatment Market, By Drug Type, 2018-2026

Table 37. France Alopecia Treatment Market, By Indication, 2018-2026

Table 38. France Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 39. Uk Alopecia Treatment Market, By Drug Type, 2018-2026

Table 40. Uk Alopecia Treatment Market, By Indication, 2018-2026

Table 41. Uk Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 42. Italy Alopecia Treatment Market, By Drug Type, 2018-2026

Table 43. Italy Alopecia Treatment Market, By Indication, 2018-2026

Table 44. Italy Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 45. Spain Alopecia Treatment Market, By Drug Type, 2018-2026

Table 46. Spain Alopecia Treatment Market, By Indication, 2018-2026

Table 47. Spain Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 48. Rest of Europe Alopecia Treatment Market, By Drug Type, 2018-2026

Table 49. Rest of Europe Alopecia Treatment Market, By Indication, 2018-2026

Table 50. Rest of Europe Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 51. Europe Alopecia Treatment Market, By Drug Type, 2018-2026

Table 52. Europe Alopecia Treatment Market, By Indication, 2018-2026

Table 53. Europe Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 54. Asia-Pacific Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 55. Japan Alopecia Treatment Market, By Drug Type, 2018-2026

Table 56. Japan Alopecia Treatment Market, By Indication, 2018-2026

Table 57. Japan Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 58. China Alopecia Treatment Market, By Drug Type, 2018-2026

Table 59. China Alopecia Treatment Market, By Indication, 2018-2026

Table 60. China Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 61. Australia Alopecia Treatment Market, By Drug Type, 2018-2026

Table 62. Australia Alopecia Treatment Market, By Indication, 2018-2026

Table 63. Australia Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 64. India Alopecia Treatment Market, By Drug Type, 2018-2026

Table 65. India Alopecia Treatment Market, By Indication, 2018-2026

Table 66. India Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 67. South Korea Alopecia Treatment Market, By Drug Type, 2018-2026

Table 68. South Korea Alopecia Treatment Market, By Indication, 2018-2026

Table 69. South Korea Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 70. Rest of Asia-Pacific Alopecia Treatment Market, By Drug Type, 2018-2026

Table 71. Rest of Asia-Pacific Alopecia Treatment Market, By Indication, 2018-2026

Table 72. Rest of Asia-Pacific Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 73. Asia-Pacific Alopecia Treatment Market, By Drug Type, 2018-2026

Table 74. Asia-Pacific Alopecia Treatment Market, By Indication, 2018-2026

Table 75. Asia-Pacific Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 76. Lamea Alopecia Treatment Market, By Country, 2018-2026 (USD Million)

Table 77. Brazil Alopecia Treatment Market, By Drug Type, 2018-2026

Table 78. Brazil Alopecia Treatment Market, By Indication, 2018-2026

Table 79. Brazil Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 80. Saudi Arabia Alopecia Treatment Market, By Drug Type, 2018-2026

Table 81. Saudi Arabia Alopecia Treatment Market, By Indication, 2018-2026

Table 82. Saudi Arabia Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 83. South Africa Alopecia Treatment Market, By Drug Type, 2018-2026

Table 84. South Africa Alopecia Treatment Market, By Indication, 2018-2026

Table 85. South Africa Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 86. Rest of Lamea Alopecia Treatment Market, By Drug Type, 2018-2026

Table 87. Rest of Lamea Alopecia Treatment Market, By Indication, 2018-2026

Table 88. Rest of Lamea Alopecia Treatment Market, By Distribution Channel, 2018-2026

Table 89. Lamea Alopecia Treatment Market, By Drug Type, 2018-2026

Table 90. Lamea Alopecia Treatment Market, By Indication, 2018-2026

Table 91. Lamea Alopecia Treatment Market, By Distribution Channel, 2018-2026

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Capillus, LLC, Cipla Inc., Daiichi Sankyo Company, Limited, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Transitions Hair, Vitabiotics Ltd., and Vita-Cos-Med Klett-Loch GmbH.